Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells

Abstract Glypican-3 (GPC3) is a cell surface heparan sulfate proteoglycan that is being evaluated as an emerging therapeutic target in hepatocellular carcinoma (HCC). GPC3 has been shown to interact with several extracellular signaling molecules, including Wnt, HGF, and Hedgehog. Here, we reported a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Panpan Meng, Yi-Fan Zhang, Wangli Zhang, Xin Chen, Tong Xu, Sheng Hu, Xinjun Liang, Mingqian Feng, Xiaoqing Yang, Mitchell Ho
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/329ef05cc3ff4f34a6454608732c6a4c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:329ef05cc3ff4f34a6454608732c6a4c
record_format dspace
spelling oai:doaj.org-article:329ef05cc3ff4f34a6454608732c6a4c2021-12-02T15:13:14ZIdentification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells10.1038/s41598-020-79524-32045-2322https://doaj.org/article/329ef05cc3ff4f34a6454608732c6a4c2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-79524-3https://doaj.org/toc/2045-2322Abstract Glypican-3 (GPC3) is a cell surface heparan sulfate proteoglycan that is being evaluated as an emerging therapeutic target in hepatocellular carcinoma (HCC). GPC3 has been shown to interact with several extracellular signaling molecules, including Wnt, HGF, and Hedgehog. Here, we reported a cell surface transmembrane protein (FAT1) as a new GPC3 interacting protein. The GPC3 binding region on FAT1 was initially mapped to the C-terminal region (Q14517, residues 3662-4181), which covered a putative receptor tyrosine phosphatase (RTP)-like domain, a Laminin G-like domain, and five EGF-like domains. Fine mapping by ELISA and flow cytometry showed that the last four EGF-like domains (residues 4013-4181) contained a specific GPC3 binding site, whereas the RTP domain (residues 3662-3788) and the downstream Laminin G-2nd EGF-like region (residues 3829-4050) had non-specific GPC3 binding. In support of their interaction, GPC3 and FAT1 behaved concomitantly or at a similar pattern, e.g. having elevated expression in HCC cells, being up-regulated under hypoxia conditions, and being able to regulate the expression of EMT-related genes Snail, Vimentin, and E-Cadherin and promoting HCC cell migration. Taken together, our study provides the initial evidence for the novel mechanism of GPC3 and FAT1 in promoting HCC cell migration.Panpan MengYi-Fan ZhangWangli ZhangXin ChenTong XuSheng HuXinjun LiangMingqian FengXiaoqing YangMitchell HoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Panpan Meng
Yi-Fan Zhang
Wangli Zhang
Xin Chen
Tong Xu
Sheng Hu
Xinjun Liang
Mingqian Feng
Xiaoqing Yang
Mitchell Ho
Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
description Abstract Glypican-3 (GPC3) is a cell surface heparan sulfate proteoglycan that is being evaluated as an emerging therapeutic target in hepatocellular carcinoma (HCC). GPC3 has been shown to interact with several extracellular signaling molecules, including Wnt, HGF, and Hedgehog. Here, we reported a cell surface transmembrane protein (FAT1) as a new GPC3 interacting protein. The GPC3 binding region on FAT1 was initially mapped to the C-terminal region (Q14517, residues 3662-4181), which covered a putative receptor tyrosine phosphatase (RTP)-like domain, a Laminin G-like domain, and five EGF-like domains. Fine mapping by ELISA and flow cytometry showed that the last four EGF-like domains (residues 4013-4181) contained a specific GPC3 binding site, whereas the RTP domain (residues 3662-3788) and the downstream Laminin G-2nd EGF-like region (residues 3829-4050) had non-specific GPC3 binding. In support of their interaction, GPC3 and FAT1 behaved concomitantly or at a similar pattern, e.g. having elevated expression in HCC cells, being up-regulated under hypoxia conditions, and being able to regulate the expression of EMT-related genes Snail, Vimentin, and E-Cadherin and promoting HCC cell migration. Taken together, our study provides the initial evidence for the novel mechanism of GPC3 and FAT1 in promoting HCC cell migration.
format article
author Panpan Meng
Yi-Fan Zhang
Wangli Zhang
Xin Chen
Tong Xu
Sheng Hu
Xinjun Liang
Mingqian Feng
Xiaoqing Yang
Mitchell Ho
author_facet Panpan Meng
Yi-Fan Zhang
Wangli Zhang
Xin Chen
Tong Xu
Sheng Hu
Xinjun Liang
Mingqian Feng
Xiaoqing Yang
Mitchell Ho
author_sort Panpan Meng
title Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
title_short Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
title_full Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
title_fullStr Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
title_full_unstemmed Identification of the atypical cadherin FAT1 as a novel glypican-3 interacting protein in liver cancer cells
title_sort identification of the atypical cadherin fat1 as a novel glypican-3 interacting protein in liver cancer cells
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/329ef05cc3ff4f34a6454608732c6a4c
work_keys_str_mv AT panpanmeng identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT yifanzhang identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT wanglizhang identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT xinchen identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT tongxu identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT shenghu identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT xinjunliang identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT mingqianfeng identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT xiaoqingyang identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
AT mitchellho identificationoftheatypicalcadherinfat1asanovelglypican3interactingproteininlivercancercells
_version_ 1718387560095416320